GORACCI, ARIANNA
 Distribuzione geografica
Continente #
EU - Europa 9.744
NA - Nord America 7.532
AS - Asia 2.938
SA - Sud America 513
AF - Africa 80
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.837
Nazione #
US - Stati Uniti d'America 7.431
RU - Federazione Russa 3.250
IT - Italia 1.757
GB - Regno Unito 1.748
CN - Cina 1.146
SG - Singapore 965
IE - Irlanda 851
SE - Svezia 482
BR - Brasile 440
UA - Ucraina 440
DE - Germania 294
HK - Hong Kong 255
FR - Francia 248
FI - Finlandia 175
PL - Polonia 175
VN - Vietnam 131
KR - Corea 119
ES - Italia 116
IN - India 77
NL - Olanda 68
JP - Giappone 64
CA - Canada 62
TR - Turchia 32
BD - Bangladesh 31
MX - Messico 29
AR - Argentina 26
CH - Svizzera 24
AU - Australia 23
IQ - Iraq 21
BE - Belgio 18
AT - Austria 17
ZA - Sudafrica 17
IR - Iran 16
CI - Costa d'Avorio 13
EG - Egitto 12
MY - Malesia 12
PK - Pakistan 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
GR - Grecia 9
PT - Portogallo 9
SA - Arabia Saudita 9
MA - Marocco 8
RO - Romania 8
UY - Uruguay 8
CL - Cile 7
HU - Ungheria 7
VE - Venezuela 7
DK - Danimarca 6
PE - Perù 6
TN - Tunisia 6
UZ - Uzbekistan 6
JO - Giordania 5
KE - Kenya 5
UG - Uganda 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
ID - Indonesia 4
KZ - Kazakistan 4
LU - Lussemburgo 4
PH - Filippine 4
AL - Albania 3
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
EU - Europa 3
GT - Guatemala 3
LT - Lituania 3
NO - Norvegia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
Totale 20.824
Città #
Southend 1.609
Dublin 840
Dallas 779
Fairfield 748
Ashburn 712
Houston 582
Singapore 522
Chandler 470
Moscow 385
Santa Clara 384
Woodbridge 372
Jacksonville 352
Beijing 329
Seattle 285
Wilmington 275
Cambridge 245
Hong Kong 244
Ann Arbor 208
Siena 167
Princeton 150
Hefei 138
Seoul 115
Nanjing 108
Rome 105
Los Angeles 98
Milan 98
Helsinki 90
Málaga 89
Florence 72
San Mateo 70
Boardman 61
Washington 58
Warsaw 54
Dong Ket 52
The Dalles 52
New York 51
Munich 49
Nanchang 43
San Diego 43
Tianjin 37
Menlo Park 35
São Paulo 35
Buffalo 33
Columbus 30
Council Bluffs 30
Shenyang 30
Norwalk 28
Ho Chi Minh City 27
London 26
Brooklyn 25
Hebei 23
Naples 23
Redondo Beach 23
Dearborn 22
Jiaxing 22
Hanoi 21
Bologna 20
Palermo 20
Prato 20
Montreal 19
San Francisco 19
Belo Horizonte 18
Brussels 18
Stockholm 18
Kunming 17
Changsha 16
Jinan 16
Trento 16
Turku 16
Bengaluru 15
Chennai 15
Chicago 15
Fremont 15
Redwood City 15
Brescia 14
Guangzhou 14
Nuremberg 14
Shanghai 14
Tokyo 14
Abidjan 13
Catania 13
Rio de Janeiro 13
Toronto 13
Zhengzhou 13
Cagliari 12
Curitiba 12
Krakow 12
Latina 12
Mestre 12
Verona 12
Vienna 12
Cascina 11
Düsseldorf 11
Frankfurt am Main 11
Orem 11
Poplar 11
Boston 10
Denver 10
Genoa 10
Kuala Lumpur 10
Totale 12.196
Nome #
Questionnaire for the Assessment of Quality of Life in Healthy Subjects (VQV-ss): Elaboration of a new instrument for the assessment of quality of life in the general population [Questionario per la Valutazione della Qualità della Vita nei soggetti sani (VQV-ss): Elaborazione di un nuovo strumento per l'assessment della Qualità della Vita nella popolazione generale] 2.656
Clinical effectiveness of parenteral trazodone for the management of psychomotor activation in patients with bipolar disorder 503
Internet Addiction Disorder in a Sample of 402 High School Students [Zespół uzależnienia od internetu w grupie 402 uczniów szkoły ̈redniej] 409
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 388
Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice 377
Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder 329
Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice 287
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 274
P.5.f.010 Evaluation of the treatment of elderly agitated patients:a preliminary study 269
P.1.k.027 Autoerotic and sexual activity in psychiatric patients 265
Mood stabilisers and pregnancy outcomes - a review 260
P.1.k.034 Psychomotor agitation in emergency medicine settings 258
P.2.f.022 Psychiatric disorder and sexual dysfunction: a pilot study 257
One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center 246
Mood disorders and bariatric surgery: a pilot study 243
Liraglutide in psychiatric patients: preliminary results 241
Personal resources and depression in schizophrenia: the role of self-esteem, resilience and internalized stigma 240
Drug safety evaluation of aripiprazole in bipolar disorder 237
Telepsychiatry: new perspectives and open issues 236
Le diverse espressioni dell'ansia e della paura: per iniziare a comprendere il mondo di coloro che soffrono di disturbi d'ansia 236
The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review 233
Early warning symptoms of schizophrenia 223
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice 219
Advances in treatment for postpartum major depressive disorder 216
P.8.b.006 Binge eating disorder and bariatric surgery: a pilot study 215
Feasibility, adherence and efficacy of liraglutide treatment in a sample of individuals with mood disorders and obesity 215
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): A Nationwide Snapshot of the Status of Treatment for Major Depression 214
Impulsiveness and psychiatric disorders: a transnosographic comparison among 179 psychiatric inpatients 212
Prevalence and correlates of Vitamin D deficiency in a sample of 290 inpatients with mental illness 208
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 207
Correlazione tra concentrazione plasmatica, efficacia e tollerabilità in un gruppo di pazienti trattati con aripiprazolo. 205
Total aripiprazole dosage: Setting up the method on the cobas® 8000 analyzer [Dosaggio dell’aripiprazolo totale: messa a punto del metodo su analizzatore Cobas 8000] 202
Affective temperaments and subthreshold symptoms spectrum in a clinical sample [Temperamenti affettivi e spettri di psicopatologia sottosoglia in un campione di popolazione clinica] 201
Quality of life, anxiety and depression in Sarcoidosis 198
Uno studio pilota sulla concentrazione plasmatica di aripiprazolo. 197
Panic agoraphobic spectrum in psychiatrically healthy subjects: impact on quality of life 196
Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice 193
Quality of life and sub threshold affective symptoms 189
Confini tra disturbo ossessivo-compulsivo e depressione: Considerazioni psicopatologiche 185
A new approach for seasonal pattern: is it related to bipolarity dimension? Findings from an Italian multicenter study 184
Clinica della mania 183
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 183
Infertility and psychiatric morbidity 182
L' impatto della psicopatologia affettiva (sia conclamata che sottosoglia) sulla qualità della vita 181
Possible involvement of opioid systems in obsessive-compulsive disorder: Psychopathological considerations [Possibile coinvolgimento del sistema oppioide nel disturbo ossessivo-compulsivo e relative considerazioni psicopatologiche] 181
Adult obsessive-compulsive disorder and quality of life outcomes: a systematic review and meta-analysis 179
Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach 178
Quality of life and subthreshold obsessive-compulsive disorder 175
S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review 175
Using sertraline in postpartum and breastfeeding: balancing risks and benefits 174
Endocrine and metabolic effects of medications used for bipolar disorder [Effetti endocrini e metabolici dei farmaci utilizzati nel disturbo bipolare] 174
Psychopharmacological treatment and personality: Cognitive schemes changes during pharmacological treatments [Psicofarmaci e personalitá: Modificazioni degli schemi cognitivi in corso di trattamenti farmacologici] 173
The effects of undertreated chronic medical illnesses in patients with severe mental disorders 172
The asthenia issue in obsessive-compulsive disorder [II problema della astenia nel disturbo ossessivo-compulsivo] 171
Social phobia spectrum and social phobic behaviours spectrum [Lo spettro della fobia sociale e lo spettro dei comportamenti fobico-sociali] 170
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder 169
Effectiveness of light therapy as adjunctive treatment in bipolar depression: A pilot study 166
Spettro dell'umore e sindrome metabolica 162
The long term-maximising potential for rehabilitation in patients with schizophrenia 162
Accuracy of self-assessment of real-life functioning in schizophrenia 162
Social cognition in people with schizophrenia: a cluster-analytic approach 161
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 160
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 159
Trazodone Contramid® in clinical practice: personalizing antidepressant intervention 159
Pathways to functional outcome in subjects with schizophrenia living in the community and their unaffected first-degree relatives 158
Biomarkers, Inflammation, and Bipolar Disorder: Association Between the Improvement of Bipolar Disorder Severity and the Improvement in C-Reactive Protein Levels After 7 Days of Inpatient Treatment 157
null 155
Per una ricerca della nuclearità maniacale al di là delle dimensioni psicopatologiche 154
Dimensional nosography of anxiety and mood disorders: The impact on quality of life [Nosografia dimensionale dei disturbi d'ansia e dell'umore: I'impatto sulla qualità di vita] 153
Benefici e potenziali rischi dell'utilizzo di antidepressivi in gravidanza: Una revisione della letteratura 153
Pharmacotherapy of binge-eating disorder: a review 153
Neuroticism and conscientiousness moderate the effect of oral medication beliefs on adherence of people with mental illness during the pandemic 151
Transnosography of aggressiveness, a psychopathological dimension of mania [Aspetti transnosografici dell'aggressività, una delle dimensioni psicopatologiche della mania] 147
Quetiapine in post-transplant acute mania/bipolar disorder NOS 145
Obsessive-compulsive disorder and quality of life outcomes: Protocol for a systematic review and meta-analysis of cross-sectional case-control studies 144
Psicopatologia della mania: dimensioni fenomenologiche 136
null 134
What can we learn from the large US Cohort study (STEP-BD) 134
Effectiveness and Tolerability of Supratherapeutic Dosing of Vortioxetine in Patients With Treatment-Resistant Depression 127
Relationship of non-suicidal self-injury and suicide attempt: a psychopathological perspective 125
Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia 124
Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa 121
Physical activity and mental health, psychological and physiological mechanisms 120
Heterozygosity for Neuronal Ceroid Lipofuscinosis predisposes to Bipolar Disorder 120
Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity-Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients 115
Human CRY1 variants associate with attention deficit/hyperactivity disorder 113
Interazione tra farmaci 112
Binge eating disorder: from clinical research to clinical practice 112
Practical guidance for prescribing trazodone extended-release in major depression 112
Development, acceptability and efficacy of a standardized healthy lifestyle intervention in recurrent depression 109
Which mixed depression model? A comparison between DSM-5-defined mixed features and Koukopoulos' criteria 109
Quality of life and sensory threshold: Study in a sample of healthy subjects [Qualità della vita e fenomenica sottosoglia: Studio in un campione di soggetti sani] 108
null 106
Pharmacokinetic Interactions 102
null 100
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 92
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 86
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 84
Principi di farmacodinamica e farmacocinetica nello switch tra antipsicotici: focus su cariprazina 84
Treatment persistence with aripiprazole once monthly: a 4-year follow-up 80
Totale 20.869
Categoria #
all - tutte 59.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.422 0 0 0 0 0 216 136 252 205 263 165 185
2021/20221.363 83 140 123 135 97 47 88 101 129 119 71 230
2022/20233.864 98 141 247 239 172 330 62 192 2.119 117 89 58
2023/20241.934 80 55 188 100 140 501 509 64 29 62 80 126
2024/20253.188 97 201 280 259 392 230 118 132 324 140 343 672
2025/20263.971 566 813 546 647 1.270 129 0 0 0 0 0 0
Totale 21.141